Request Deal Involvement

Impilo-backed Scantox completed the acquisition of the neuropharmacology division of QPS Austria.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Lincoln International

financial advisors

Lincoln International

Ernst & Young

financial advisors

Ernst & Young

LEK Consulting

commercial advisors

LEK Consulting

Accura Advokatpartnerselskab

legal advisors

Accura Advokatpartnerselskab

Dorda Rechtsanwalte

legal advisors

Dorda Rechtsanwalte

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

Ropes & Gray

legal advisors

Ropes & Gray

Wolf Theiss

legal advisors

Wolf Theiss

KPMG

tax advisors

KPMG

or

Principals

IMPILO

bidder

IMPILO

SCANTOX

bidder

SCANTOX

QPS AUSTRIA

vendor

QPS AUSTRIA

SCANTOX NEURO (EX-QPS NEUROPHARMACOLOGY)

target

SCANTOX NEURO (EX-QPS NEUROPHARMACOLOGY)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Impilo-backed Scantox completed the acquisition of the neuropharmacology division of QPS Austria.